1. Home
  2. MPWR vs RMD Comparison

MPWR vs RMD Comparison

Compare MPWR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monolithic Power Systems Inc.

MPWR

Monolithic Power Systems Inc.

HOLD

Current Price

$1,201.06

Market Cap

45.9B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$258.07

Market Cap

36.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPWR
RMD
Founded
1997
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.9B
36.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MPWR
RMD
Price
$1,201.06
$258.07
Analyst Decision
Strong Buy
Buy
Analyst Count
14
11
Target Price
$1,122.93
$293.70
AVG Volume (30 Days)
632.7K
1.2M
Earning Date
05-07-2026
01-01-0001
Dividend Yield
0.68%
0.94%
EPS Growth
317.69
N/A
EPS
9.28
N/A
Revenue
$333,067,000.00
N/A
Revenue This Year
$23.24
$10.64
Revenue Next Year
$18.29
$7.38
P/E Ratio
$126.20
$25.61
Revenue Growth
17.89
N/A
52 Week Low
$438.86
$199.92
52 Week High
$1,250.00
$293.81

Technical Indicators

Market Signals
Indicator
MPWR
RMD
Relative Strength Index (RSI) 60.49 50.68
Support Level $1,152.85 $245.65
Resistance Level $1,202.92 $262.17
Average True Range (ATR) 60.32 8.06
MACD -4.43 -0.85
Stochastic Oscillator 66.43 38.04

Price Performance

Historical Comparison
MPWR
RMD

About MPWR Monolithic Power Systems Inc.

Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: